SFN and breast carcinoma: We previously found that treatment of ZLM-7 could upregulate the expression of 14-3-3 sigma in breast cancer cell lines (data unpublished), prompting us to explore the action of ZLM-7 in the regulation of the cell cycle via 14-3-3 sigma in the present study.